scopolamine transdermal system

FDA Drug Profile — Scopolamine Transdermal System

scopolamine transdermal system is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Scopolamine Transdermal System. Available dosage form: patch, extended release.

Drug details

Generic Name
scopolamine transdermal system
Brand Names
Scopolamine Transdermal System
Application Number
ANDA078830
Sponsor
Padagis Israel Pharmaceuticals Ltd
NDC Codes
2
Dosage Forms
PATCH, EXTENDED RELEASE
Routes
TRANSDERMAL
Active Ingredients
SCOPOLAMINE

Indications and Usage

1 INDICATIONS AND USAGE Scopolamine transdermal system is indicated in adults for the prevention of: • nausea and vomiting associated with motion sickness. • post-operative nausea and vomiting (PONV) associated with recovery from anesthesia and/or opiate analgesia and surgery. Scopolamine transdermal system is an anticholinergic indicated in adults for the prevention of: • nausea and vomiting associated with motion sickness. ( 1 ) • post-operative nausea and vomiting (PONV) associated with recovery from anesthesia and/or opiate analgesia and surgery. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.